[Clinical studies on cefsulodin in the field of pediatrics].
An anti-P. aeruginosa, cephalosporin, cefsulodin (CFS) was administered to 2 patients who were affected with inveterate urinary tract infection at ages of 1 year 8 months and 2 years, and another with pneumonia combined with lung fibrosis and bronchiectasia at 3 years. The clinical responses in 3 cases were "good" in 2 and "fair" in 1. The bacteriological responses to 3 strains of P. aeruginosa isolated in this clinical study were "eradicated" in 1, "decreased" in 1, and "unchanged" in 1. No side effects were observed.